AbbVie Unit Settles New York Opioid Case for $200 Mln as Trial Winds Down

Drugmaker AbbVie Inc agreed to pay $200 million to settle claims by New York that it helped fuel an epidemic of opioid addiction in the state, on the day jurors were expected to hear closing arguments at the end of a five-month trial. Read More